Thorvald "Thor" Nagel
Board Member
Immunic, Inc. (IMUX)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Thorvald "Thor" Nagel
Thorvald "Thor" Nagel is recorded as Board Member at Immunic, Inc. (IMUX). Immunic, Inc. reported in an 8-K filed February 13, 2026 that Thorvald "Thor" Nagel was appointed Class III director, effective February 12, 2026.
“On February 12, 2026, the board of directors of the Company (the "Board"), following the recommendation of the Nominating and Corporate Governance Committee of the Board (the "Committee"), appointed Thor Nagel to the Board until the 2026 annual meeting of stockholders as a Class III director or until his respective successors are duly elected and qualified.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2026-02-12–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Immunic, Inc.
Other people whose current roles at this company are on record from its filings.
- Dr. Daniel Vitt CEO
- Duane D. Nash CEO
- Duane Nash CEO
- Erik Lundgren CEO, Board Member
- Russell J. Cox CEO
- Michael W. Bonney Chairman
- Simona Skerjanec Chairman, Board Member
- Glenn Whaley CFO
- Jason Tardio COO
- Inderpal Singh General Counsel
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.